Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 21, 2017; 23(47): 8300-8307
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8300
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8300
Table 6 Allele and genotype frequencies of NOS2A TAAA polymorphism in inflammatory bowel disease patients and controls n (%)
Controls | IBD patients | CD patients | UC patients | |
n = 295 | n = 190 | n = 132 | n = 58 | |
Genotype | ||||
220/220 | 189 (64.07) | 132 (69.47) | 90 (68.18) | 42 (72.41) |
220/224 | 97 (32.88) | 49 (25.79) | 34 (25.76) | 15 (25.86) |
224/224 | 9 (3.05) | 9 (4.74) | 8 (6.06) | 1 (1.72) |
Allele | 2n = 590 | 2n = 380 | 2n = 264 | 2n = 116 |
220 | 475 (80.5) | 313 (82.4) | 214 (81) | 99 (85.3) |
224 | 115 (19.5) | 67 (17.6) | 50 (19) | 17 (14.7) |
- Citation: Senhaji N, Nadifi S, Zaid Y, Serrano A, Rodriguez DAL, Serbati N, Karkouri M, Badre W, Martín J. Polymorphisms in oxidative pathway related genes and susceptibility to inflammatory bowel disease. World J Gastroenterol 2017; 23(47): 8300-8307
- URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8300.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i47.8300